Balchem Co. (NASDAQ:BCPC) Shares Sold by Sei Investments Co.

Sei Investments Co. lowered its position in Balchem Co. (NASDAQ:BCPC) by 1.6% during the fourth quarter, Holdings Channel.com reports. The fund owned 107,424 shares of the basic materials company’s stock after selling 1,757 shares during the quarter. Sei Investments Co.’s holdings in Balchem were worth $17,510,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in BCPC. FMR LLC lifted its stake in shares of Balchem by 944.3% in the 3rd quarter. FMR LLC now owns 497,495 shares of the basic materials company’s stock valued at $87,559,000 after purchasing an additional 449,854 shares in the last quarter. Proficio Capital Partners LLC acquired a new position in Balchem during the fourth quarter valued at approximately $23,628,000. Raymond James Financial Inc. purchased a new stake in Balchem during the fourth quarter worth approximately $13,359,000. Barclays PLC increased its position in shares of Balchem by 405.8% in the third quarter. Barclays PLC now owns 60,777 shares of the basic materials company’s stock worth $10,695,000 after acquiring an additional 48,762 shares in the last quarter. Finally, Geneva Capital Management LLC raised its stake in shares of Balchem by 5.1% in the 4th quarter. Geneva Capital Management LLC now owns 819,746 shares of the basic materials company’s stock valued at $133,615,000 after acquiring an additional 39,877 shares during the period. Hedge funds and other institutional investors own 87.91% of the company’s stock.

Balchem Stock Performance

Shares of BCPC stock opened at $166.11 on Friday. The company’s fifty day moving average price is $165.18 and its two-hundred day moving average price is $169.26. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16. The firm has a market capitalization of $5.40 billion, a P/E ratio of 42.27, a P/E/G ratio of 4.41 and a beta of 0.63. Balchem Co. has a 12 month low of $137.69 and a 12 month high of $186.03.

Balchem (NASDAQ:BCPC) last issued its quarterly earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing analysts’ consensus estimates of $1.11 by ($0.08). Balchem had a net margin of 13.47% and a return on equity of 11.37%. The business had revenue of $240.00 million during the quarter, compared to analysts’ expectations of $239.96 million. On average, research analysts anticipate that Balchem Co. will post 4.64 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

BCPC has been the subject of a number of research reports. StockNews.com cut shares of Balchem from a “buy” rating to a “hold” rating in a research report on Tuesday, February 25th. HC Wainwright reiterated a “buy” rating and set a $190.00 target price on shares of Balchem in a report on Monday, February 24th. Finally, Sidoti upgraded Balchem to a “hold” rating in a report on Tuesday, February 25th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.